Concerning chemicals from the wear of climbing shoes cause trouble in indoor halls
Peer-Reviewed Publication
Updates every hour. Last Updated: 22-Jun-2025 04:10 ET (22-Jun-2025 08:10 GMT/UTC)
A pioneering study uncovers crucial immune dynamics in hepatitis B, offering new insights into how immune responses evolve throughout the different clinical phases of Hepatitis B virus (HBV) infection. Researchers analyzed liver and blood samples from patients in various clinical phases—acute hepatitis B (AHB), immune tolerant (IT), immune active (IA), and inactive chronic infection (ICI)—using single-cell RNA and TCR/BCR sequencing. The findings highlight critical immune cell subsets and potential molecular mechanisms that drive disease progression, providing valuable targets for the development of future immunomodulatory therapies.
In April 2025, the internationally renowned academic journal The Journal of the American Medical Association (JAMA) (Impact Factor: 63.5) published online a study titled “Non-Risk-Based Lung Cancer Screening With Low-Dose Computed Tomography”, led by Professors Jianxing He and Wenhua Liang from the First Affiliated Hospital of Guangzhou Medical University and the National Clinical Research Center for Respiratory Disease.
This research, focusing on lung cancer screening strategies, revealed that the non-risk-based (universal) screening approach - unrestricted by traditional high-risk criteria - achieved a comparable detection rate of lung cancer among individuals not classified as high-risk relative to those who were. The findings underscore the necessity of evaluating the effectiveness of lung cancer screening in non-high-risk populations and developing biomarker-based enrichment strategies to refine pre-screening selection in this subgroup.
New research from UTHealth Houston reveals that substance use disorders accelerate biological aging in the brain through substance-specific molecular mechanisms. The study, published in Genomic Psychiatry, identified distinct genetic and biological pathways that contribute to premature aging in individuals with alcohol, opioid, and stimulant use disorders, offering potential targets for future therapeutic interventions.
A newly published personal tribute in Brain Medicine offers a rare window into the remarkable life and influence of Dr. Seymour "Si" Reichlin, who turned 100 in June 2024. Written by former endocrine fellow Dr. Leonard Kapcala, the article chronicles their 48-year relationship and illuminates how Reichlin's brilliance, mentorship, and humanity shaped generations of neuroendocrinology researchers.